Zoetis [ZTS] vs Viatris [VTRS] Detailed Stock Comparison
Zoetis
NYSE
Loading...
Viatris
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Zoetis wins in 12 metrics, Viatris wins in 8 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zoetis | Viatris | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.36 | 235.80 | Zoetis |
| Price-to-Book Ratio | 13.14 | 0.80 | Viatris |
| Debt-to-Equity Ratio | 137.01 | 94.78 | Viatris |
| PEG Ratio | 23.24 | -2.36 | Viatris |
| EV/EBITDA | 17.91 | 6.34 | Viatris |
| Profit Margin (TTM) | 27.83% | -24.57% | Zoetis |
| Operating Margin (TTM) | 40.20% | 9.95% | Zoetis |
| EBITDA Margin (TTM) | 40.20% | 9.95% | Zoetis |
| Return on Equity | 52.77% | -19.77% | Zoetis |
| Return on Assets (TTM) | 15.37% | 2.30% | Zoetis |
| Free Cash Flow (TTM) | $2.30B | $1.94B | Zoetis |
| Dividend Yield | 1.11% | 6.19% | Viatris |
| 1-Year Return | -16.11% | -9.01% | Viatris |
| Price-to-Sales Ratio (TTM) | 6.96 | 0.88 | Viatris |
| Enterprise Value | $70.67B | $26.09B | Zoetis |
| EV/Revenue Ratio | 7.53 | 1.85 | Viatris |
| Gross Profit Margin (TTM) | 73.62% | 37.21% | Zoetis |
| Revenue per Share (TTM) | $21 | $12 | Zoetis |
| Earnings per Share (Diluted) | $5.81 | $-2.93 | Zoetis |
| Beta (Stock Volatility) | 0.88 | 0.90 | Zoetis |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zoetis vs Viatris Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zoetis | 1.51% | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% |
| Viatris | -0.75% | 9.38% | 18.81% | 20.71% | -2.30% | -14.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zoetis | -16.11% | -9.09% | -2.69% | 242.31% | 396.97% | 396.97% |
| Viatris | -9.01% | 0.38% | -33.65% | -79.40% | -39.51% | -41.64% |
Performance & Financial Health Analysis: Zoetis vs Viatris
| Metric | ZTS | VTRS |
|---|---|---|
| Market Information | ||
| Market Cap | $65.30B | $12.46B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 4,111,510 | 10,505,913 |
| 90 Day Avg. Volume | 3,459,870 | 8,608,808 |
| Last Close | $167.10 | $10.61 |
| 52 Week Range | $139.70 - $200.33 | $6.85 - $13.55 |
| % from 52W High | -16.59% | -21.70% |
| All-Time High | $249.27 (Dec 27, 2021) | $76.69 (Apr 20, 2015) |
| % from All-Time High | -32.96% | -86.17% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | -0.06% |
| Quarterly Earnings Growth | 0.15% | -0.06% |
| Financial Health | ||
| Profit Margin (TTM) | 0.28% | -0.25% |
| Operating Margin (TTM) | 0.40% | 0.10% |
| Return on Equity (TTM) | 0.53% | -0.20% |
| Debt to Equity (MRQ) | 137.01 | 94.78 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.21 | $13.36 |
| Cash per Share (MRQ) | $3.28 | $0.69 |
| Operating Cash Flow (TTM) | $2.93B | $2.06B |
| Levered Free Cash Flow (TTM) | $2.29B | $4.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.11% | 6.19% |
| Last 12-Month Dividend | $1.86 | $0.60 |
Valuation & Enterprise Metrics Analysis: Zoetis vs Viatris
| Metric | ZTS | VTRS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.36 | 235.80 |
| Forward P/E | 23.24 | 4.00 |
| PEG Ratio | 23.24 | -2.36 |
| Price to Sales (TTM) | 6.96 | 0.88 |
| Price to Book (MRQ) | 13.14 | 0.80 |
| Market Capitalization | ||
| Market Capitalization | $65.30B | $12.46B |
| Enterprise Value | $70.67B | $26.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.53 | 1.85 |
| Enterprise to EBITDA | 17.91 | 6.34 |
| Risk & Other Metrics | ||
| Beta | 0.88 | 0.90 |
| Book Value per Share (MRQ) | $11.21 | $13.36 |
Financial Statements Comparison: Zoetis vs Viatris
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZTS | VTRS |
|---|---|---|
| Revenue/Sales | $2.22B | $3.25B |
| Cost of Goods Sold | $622.00M | $2.09B |
| Gross Profit | $1.60B | $1.16B |
| Research & Development | $157.00M | $222.00M |
| Operating Income (EBIT) | $846.00M | $-8.90M |
| EBITDA | $991.00M | $556.50M |
| Pre-Tax Income | $810.00M | $-3.10B |
| Income Tax | $179.00M | $-55.00M |
| Net Income (Profit) | $631.00M | $-3.04B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZTS | VTRS |
|---|---|---|
| Cash & Equivalents | $1.72B | $755.00M |
| Total Current Assets | $5.88B | $9.62B |
| Total Current Liabilities | $3.39B | $5.72B |
| Long-Term Debt | $5.40B | $14.35B |
| Total Shareholders Equity | $4.66B | $15.65B |
| Retained Earnings | $12.38B | $227.90M |
| Property, Plant & Equipment | $6.36B | $265.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZTS | VTRS |
|---|---|---|
| Operating Cash Flow | $567.00M | $-2.44B |
| Capital Expenditures | N/A | $11.30M |
| Free Cash Flow | $438.00M | $459.10M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-443.00M | $-175.40M |
Short Interest & Institutional Ownership Analysis
| Metric | ZTS | VTRS |
|---|---|---|
| Shares Short | 7.85M | 37.17M |
| Short Ratio | 2.67 | 4.46 |
| Short % of Float | 0.02% | 0.04% |
| Average Daily Volume (10 Day) | 4,111,510 | 10,505,913 |
| Average Daily Volume (90 Day) | 3,459,870 | 8,608,808 |
| Shares Outstanding | 448.47M | 1.19B |
| Float Shares | 442.37M | 1.16B |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.98% | 0.83% |
Dividend Analysis & Yield Comparison: Zoetis vs Viatris
| Metric | ZTS | VTRS |
|---|---|---|
| Last 12-Month Dividend | $1.86 | $0.60 |
| Last 12-Month Dividend Yield | 1.11% | 6.19% |
| 3-Year Avg Annual Dividend | $1.63 | $0.52 |
| 3-Year Avg Dividend Yield | 0.24% | 1.17% |
| 3-Year Total Dividends | $4.90 | $1.56 |
| Ex-Dividend Date | Apr 21, 2025 | Aug 22, 2025 |